TIFFANY ADAMS: Open Payments
NPI 1427556125 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 45 payments from 16 companies in 2025. Trend: 2023 $709 · 2024 $648 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 13 | $263 |
| ABBVIE INC. | 4 | $172 |
| Merck Sharp & Dohme LLC | 6 | $110 |
| Melinta Therapeutics, LLC | 4 | $81 |
| Shionogi Inc | 4 | $76 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Insmed, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| CeQur Corporation | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
Products named: NUZYRA, EMBLAVEO, ZERBAXA, Rezzayo, Fetroja, VOWST, Arikayce, DALVANCE.
Industry payments across KY — which companies pay providers there.
